“Your tests are normal.” Words that people might hear, yet their lives are anything but. In a new op-ed, Tonix CEO @SethLederman discusses why patient experiences aligned with the latest advances in medicine must remain central to care. Read more: sethmlederman.substack.com/p… #Fibromyalgia #ChronicPain #Tonix

On Fibromyalgia Awareness Day, watch a new video episode of The Fibro Show featuring Tonix CEO @SethLederman Lederman in conversation with Sharon Waldrop, host and Fibromyalgia Association founder. Tonix is dedicated to supporting the fibromyalgia community. Alongside The Fibro Show, we are sponosring the Fibromyalgia Association’s 25th Annual Fibromyalgia Awareness Day. Register: eventbrite.com/e/25th-annual… #FibromyalgiaAwarenessMonth #FibromyalgiaAwarenessDay #Fibromyalgia

Check out new coverage from @PharmaVoice on efforts to address #LymeDisease, including Tonix’s investigational #monoclonalantibody, TNX-4800, for prevention in the U.S. Learn more: pharmavoice.com/news/pfizer-… #InfectiousDisease #Tonix #Biotech

Clinical Trials Arena recently highlighted Tonix’s Phase 2 ready investigational human #monoclonalantibody, TNX-4800, for #Lymedisease prevention in the U.S. Read more: clinicaltrialsarena.com/news… #InfectiousDisease #Tonix #Biotech

Fibromyalgia affects millions, yet diagnosis is often delayed for years. In a new post, Tonix CEO @SethLederman, MD, reflects on the scientific innovation and care delivery gap for patients. open.substack.com/pub/sethml… #Fibromyalgia #ChronicPain

A recent @nytimes article draws important attention to the long and misunderstood journey of conditions including endometriosis and #fibromyalgia. Fortunately, it seems a broader shift is underway in how #chronicpain is understood. nytimes.com/2026/03/14/well/…

With ~70 million Americans living, working, or vacationing in tick-endemic zones, Lyme disease is a public health crisis. There’s no FDA-approved vaccine or preventive therapy in the U.S, which Tonix hopes to address with our Phase 2 ready program. nytimes.com/2026/03/16/nyreg…

Mpox is an emerging infectious disease that is now surfacing globally, including NY and the U.S. (with risk remaining low). Tonix is developing an attenuated investigational vaccine with the potential capability to protect against smallpox and mpox. abc7ny.com/post/first-known-…

Watch our CEO @SethLederman, M.D., discuss our transformation into a commercial stage company with @ZacksResearch: ir.tonixpharma.com/news-even… #Tonix #TNXP #Fibromyalgia #LymeDisease

Maine is facing record Lyme disease cases, and new prevention strategies are urgently needed. @newscentermaine featured Tonix’s work on a long-acting antibody approach to Lyme prevention, with expert insights from CEO @SethLederman. Thank you to @vivienleigh6 for covering this important topic! Read more: newscentermaine.com/article/… #LymeDisease #PublicHealth #Biotech

#MichaelJackson's death wasn’t just a tragedy, it was a failure of how medicine treats chronic pain and sleep disorders. In RealClear Health, our CEO, @SethLederman examines fibromyalgia, fragmented care, and why symptom-chasing with risky drugs still persists today. We know better now. Care must change. More essays and reflections are available on Seth’s Substack: bit.ly/4rAbhr3 #ChronicPain #Fibromyalgia #SleepHealth #PainScience #NonOpioidCare #Tonix Read article: bit.ly/4qWynYR